TY - JOUR
T1 - Mesenchymal stem cell-educated macrophages
T2 - A novel type of alternatively activated macrophages
AU - Kim, Jaehyup
AU - Hematti, Peiman
N1 - Funding Information:
This work was supported by National Institutes of Health/National Heart, Lung and Blood Institute (Bethesda, MD, USA) HL081076 K08 grant (to P.H.) and also by funding from University of Wisconsin Carbone Cancer Center (Madison, WI, USA). The authors gratefully thank Dr. Laura Hogan for the critical reading of the manuscript.
PY - 2009/12
Y1 - 2009/12
N2 - Objective: Mesenchymal stem cells (MSCs) are capable of modulating the immune system through interaction with a wide range of immune cells. This study investigates the hypothesis that interaction of MSCs with macrophages could play a significant role in their antiinflammatory/immune modulatory effects. Materials and Methods: MSCs were derived from bone marrow and monocytes were isolated from peripheral blood of healthy donors. We cultured human monocytes for 7 days without any added cytokines to generate macrophages, and then cocultured them for 3 more days with culture-expanded MSCs. We used cell surface antigen expression and intracellular cytokine expression patterns to study the immunophenotype of macrophages at the end of this coculture period, and phagocytic assays to investigate their functional activity in vitro. Results: Macrophages cocultured with MSCs consistently showed high-level expression of CD206, a marker of alternatively activated macrophages. Furthermore, these macrophages expressed high levels of interleukin (IL)-10 and low levels of IL-12, as determined by intracellular staining, typical of alternatively activated macrophages. However, macrophages cocultured with MSCs also expressed high levels of IL-6 and low levels of tumor necrosis factor-alpha (TNF-α) compared to controls. Functionally, macrophages cocultured with MSCs showed a higher level of phagocytic activity. Conclusions: We describe a novel type of human macrophage generated in vitro after coculture with MSCs that assumes an immunophenotype defined as IL-10-high, IL-12-low, IL-6-high, and TNF-α-low secreting cells. These MSC-educated macrophages may be a unique and novel type of alternatively activated macrophage with a potentially significant role in tissue repair.
AB - Objective: Mesenchymal stem cells (MSCs) are capable of modulating the immune system through interaction with a wide range of immune cells. This study investigates the hypothesis that interaction of MSCs with macrophages could play a significant role in their antiinflammatory/immune modulatory effects. Materials and Methods: MSCs were derived from bone marrow and monocytes were isolated from peripheral blood of healthy donors. We cultured human monocytes for 7 days without any added cytokines to generate macrophages, and then cocultured them for 3 more days with culture-expanded MSCs. We used cell surface antigen expression and intracellular cytokine expression patterns to study the immunophenotype of macrophages at the end of this coculture period, and phagocytic assays to investigate their functional activity in vitro. Results: Macrophages cocultured with MSCs consistently showed high-level expression of CD206, a marker of alternatively activated macrophages. Furthermore, these macrophages expressed high levels of interleukin (IL)-10 and low levels of IL-12, as determined by intracellular staining, typical of alternatively activated macrophages. However, macrophages cocultured with MSCs also expressed high levels of IL-6 and low levels of tumor necrosis factor-alpha (TNF-α) compared to controls. Functionally, macrophages cocultured with MSCs showed a higher level of phagocytic activity. Conclusions: We describe a novel type of human macrophage generated in vitro after coculture with MSCs that assumes an immunophenotype defined as IL-10-high, IL-12-low, IL-6-high, and TNF-α-low secreting cells. These MSC-educated macrophages may be a unique and novel type of alternatively activated macrophage with a potentially significant role in tissue repair.
UR - http://www.scopus.com/inward/record.url?scp=70449527554&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70449527554&partnerID=8YFLogxK
U2 - 10.1016/j.exphem.2009.09.004
DO - 10.1016/j.exphem.2009.09.004
M3 - Article
C2 - 19772890
AN - SCOPUS:70449527554
SN - 0301-472X
VL - 37
SP - 1445
EP - 1453
JO - Experimental Hematology
JF - Experimental Hematology
IS - 12
ER -